-
BioDelivery Sciences Appoints Thomas Alonzo To Board
4/29/2013
|
|
|
-
BioDelivery Sciences Enters Into Worldwide Licensing Agreement With Arcion Therapeutics
3/26/2013
|
|
|
-
BioDelivery Sciences Posts FY12 EPS Of $0.05 Vs. Loss $0.82 Year Ago
3/18/2013
|
|
|
|
|
|
|
|
|
-
BioDelivery Sciences Says Completes BNX Safety Study; BNX Remains On Track For Mid-year NDA Submission
1/22/2013
|